skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

82 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

J&J's Spravato Set For EU Launches Soon

23 Oct 2019

Ketamine-Like Antidepressant Backed By CHMP If the nasal spray is approved by the European Commission, seven months after getting the green light in the US, Spravato will offer the first new mechanism of action in 30 years to treat major depressive disorder.

Topic drug-approval drug-development-landscape

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Survival Data Boost Lilly & Novartis's CDK4/6 Assault On Pfizer's Ibrance In Metastatic Breast Cancer

By Alex Shimmings 18 Oct 2019

Pfizer’s dominance of the CDK4/6 inhibitor market will come under renewed pressure as the MONALEESA-3 and MONARCH-2 studies for Novartis’s Kisqali and Lilly’s Verzenio presented at ESMO confirmed their survival benefits in advanced hormone-receptor-positive, HER2-negative breast cancer. The data firmly push the drug class into front-line advanced setting in these patients.

Topic cancer drug-development-landscape research

Trialtrove: 医療用医薬品の臨床試験情報データベース

2018年に開始された臨床試験を総括・無料ホワイトペーパー

18 Oct 2019

2018年に開始された第I相臨床試験~第III相臨床試験を総括する無料ホワイトペーパー「2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts(全22頁)」をダウンロードできます。2018年に開始された臨床試験とその競合状況を鳥の目で分析して、バイオ医薬品産業全体のトレンドを明らかにしています。また、個々の企業の戦略や優先課題も考察しています。

Topic drug-development-landscape biopharmaceutical business-strategies

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

18 Oct 2019

Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

Drug developers and payers are coming together long before product approvals to work out payment options for high-cost, high-impact cell and gene therapies, but challenges like portability of commercially insured patients and Medicaid best price requirements remain.

Topic cell-and-gene-therapy drug-development-landscape

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetr...

Q4 2019 Outlook Report Extract

16 Oct 2019

What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.

Topic clinical-trials drug-development-landscape

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Pink Sheet Sample Article Pack: The Hottest Topics in Pharma Regulatory Compliance

16 Oct 2019

Pink Sheet Sample Article Pack: The Hottest Topics in Pharma Regulatory Compliance

When you look at newly approved drugs, the latest product reviews and the decisions made during the process, you can gain critical insights to inform your own strategic decisions. That’s what Pink Sheet delivers, and now you can try it for free.

Topic Drug approval Drug development landscape

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Pink Sheet Performance Trackers: Navigate a complex world with the regulatory performance trackers from Pink Sheet

16 Oct 2019

 Pink Sheet Performance Trackers: Navigate a complex world with the regulatory performance trackers from Pink Sheet

Keep track of compliance, legislation, policy regulations, and industry developments with the expertise of our worldwide network of expert analysts and journalists on the ground in key global regions.

Topic drug-development-landscape drug-review fda

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Opioids Crisis Commercial Implications for an Embattled Industry

14 Oct 2019

Opioids Crisis Commercial Implications for an Embattled Industry

Find out how the consequences of the opioids crisis is affecting the pharma industry, from shaping the way deals are made, to transforming the development of new categories of drugs. Scrip brings you the implications behind the headlines in an essential free article pack.

Topic drug-development-landscape fda

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。